NEA Management Company LLC Trims Stake in Senti Biosciences, Inc. (NASDAQ:SNTI)

NEA Management Company LLC lowered its position in Senti Biosciences, Inc. (NASDAQ:SNTI) by 90.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 442,615 shares of the company’s stock after selling 3,983,536 shares during the quarter. NEA Management Company LLC owned about 9.66% of Senti Biosciences worth $1,000,000 at the end of the most recent reporting period.

Senti Biosciences Stock Performance

NASDAQ SNTI opened at $2.16 on Friday. The company’s 50-day moving average price is $2.23 and its 200-day moving average price is $2.60. Senti Biosciences, Inc. has a 12 month low of $1.52 and a 12 month high of $7.43.

Senti Biosciences Profile

Senti Biosciences, Inc operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications.